Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to -$8.4 million.

  • Harvard Bioscience's Other Gross PP&E Adjustments fell 721.68% to -$8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 million, marking a year-over-year decrease of 721.68%. This contributed to the annual value of $14.2 million for FY2024, which is 1026.08% up from last year.
  • Harvard Bioscience's Other Gross PP&E Adjustments amounted to -$8.4 million in Q3 2025, which was down 721.68% from -$8.9 million recorded in Q2 2025.
  • Harvard Bioscience's 5-year Other Gross PP&E Adjustments high stood at $14.2 million for Q4 2024, and its period low was -$11.8 million during Q1 2021.
  • Its 5-year average for Other Gross PP&E Adjustments is -$4.2 million, with a median of -$8.0 million in 2023.
  • In the last 5 years, Harvard Bioscience's Other Gross PP&E Adjustments tumbled by 25647.5% in 2021 and then skyrocketed by 4445.36% in 2023.
  • Over the past 5 years, Harvard Bioscience's Other Gross PP&E Adjustments (Quarter) stood at $10.4 million in 2021, then rose by 12.84% to $11.7 million in 2022, then grew by 10.26% to $12.9 million in 2023, then increased by 10.26% to $14.2 million in 2024, then plummeted by 158.91% to -$8.4 million in 2025.
  • Its last three reported values are -$8.4 million in Q3 2025, -$8.9 million for Q2 2025, and -$10.3 million during Q1 2025.